Envista (NASDAQ:NVST) posted its quarterly earnings results on Thursday. The company reported ($0.10) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.24) by $0.14, MarketWatch Earnings reports. The company had revenue of $362.00 million during the quarter, compared to analyst estimates of $346.33 million.

NVST stock traded down $0.72 during mid-day trading on Friday, reaching $21.87. 3,494,357 shares of the stock traded hands, compared to its average volume of 3,032,295. Envista has a 52 week low of $10.08 and a 52 week high of $33.30. The business has a 50-day moving average of $20.94 and a two-hundred day moving average of $21.74.

A number of equities analysts have recently weighed in on the stock. Bank of America upped their price target on shares of Envista from $21.50 to $23.00 and gave the stock a “neutral” rating in a research note on Monday, July 20th. Zacks Investment Research raised shares of Envista from a “strong sell” rating to a “hold” rating in a research report on Wednesday, April 15th. Piper Sandler increased their target price on shares of Envista from $20.00 to $22.00 and gave the stock a “neutral” rating in a research report on Friday. Credit Suisse Group lowered their target price on shares of Envista from $23.00 to $21.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 13th. Finally, JPMorgan Chase & Co. increased their target price on shares of Envista from $22.00 to $24.00 and gave the stock an “overweight” rating in a research report on Monday, June 1st. Five investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. The company has a consensus rating of “Buy” and a consensus price target of $27.27.

About Envista

Envista Holdings Corporation manufactures and sells dental products in the United States and internationally. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, prefabricated and custom-built prosthetics, and dental eye loupes to oral surgeons, prosthodontists, and periodontists under the brands, including Nobel Biocare, Alpha Bio Tec, Implant Direct, Nobel Procera, and Orascoptic; and brackets and wires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Ormco, Insignia, AOA, and Spark brands.

Read More: What is the Hang Seng index?  

Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.